Viper
Ultrasonic Pharmacomechanical Thrombolysis System
ViperⓇ Ultrasonic Pharmacomechanical Thrombolysis Catheter is a minimally invasive system for dissolving thrombus that is designed for controlled ultrasonic infusion therapy of tPA along with US waves. It increases the effects of tPA by thinning the fibrin and increasing porosity.
ViperⓇUltrasonic Pharmacomechanical Thrombolysis Catheter is a minimally invasive system for dissolving thrombus that designed for controlled ultrasonic infusion therapy of tPA along with US waves. It increases the effects of tPA by thinning the fibrin and increasing porosity. tPA can be pushed deeper inside the thrombus, increasing the drugs effectivity.
Targets the Thrombus Safely
- Lowers the risk of bleeding and other complications.
- Dissolves clots without damaging vessels, valves or walls.
The thrombolysis catheter, which is advanced directly and advanced over the wire, is used to open the lumen and dissolve the thrombus in acute occlusions. The system has a specially designed tip to dissolve the thrombus. Pharmacomechanical thrombolysis is performed by delivering the necessary fluids to the vein with a special tip and administering thrombolytic drugs.
Detailed specifications
Targets the Thrombus Safely
- Lowers the risk of bleeding and other complications.
- Dissolves clots without damaging vessels, valves, or walls.
Effective Solutions in Acute Massive Pulmonary Embolism
- Reduces dosage requirements by as much as 70% compared to standard, catheter-directed drug therapy.
- Requires up to 4x less drug dosage than traditional systemic delivery.
Over the guide wire system and 90, 135, 150, and 200 cm catheter length. Allows safe access to the clotted target vessel including the pulmonary artery in PE cases.
The ultrasonic core generates an acoustic field that greatly accelerates lytic dispersion by driving the drug deeper into the clot and unwinding the fibrin to expose plasminogen receptor sites.
FAST AND SAFE THROMBUS TREATMENT
- Pulmonary embolism
- Deep vein thrombosis
- Peripheral arterial occlusions
The ViperⓇPharmacomechanical Thrombolysis Catheter offers a minimally invasive system for resolving thrombi. The space formed by the ultrasonic nuclei greatly accelerates the lytic dispersion, directing the drug deeper inside the clot and dissolving the fibrin to expose the plasminogen receptor sites.
The ViperⓇPharmacomechanical Thrombolysis Catheter provides high-frequency (2-3 MHz), low-energy ultrasound waves to the lesion thanks to the piezoelectric crystals it has. Targeted ultrasound waves accelerate thrombus dissolution by relaxing the fibrin matrix. This way;
- Shortens the time required for clot resolution.
- It reduces the need for dosage by about 65% compared to standard treatment and provides further thrombus removal and clinical improvement.
- Provides more effective drug administration, and requires a drug dosage 4 times lower than standard therapy.
135 cm working length and 20, 30, 40, and 50 cm treatment zone
Acoustic Pulse Thrombolysis
- Quickness, the clot dissolution
- Results in quality clinical outcomes.
- Increases clot removal and enhances clinical improvement compared to either standard catheter-directed drug therapy or thrombectomy
- Requires significantly shorter treatment times compared to standard CDT
PHARMACOMECHANICAL THROMBOLYSIS OF PULMONARY ARTERY/THROMBECTOMY CATHETERS
ViperⓇPharmacomechanical Thrombolysis Catheter Created using Ultrasonic Core Technology loosens and thins the fibrin strands. it reveals more drug receptor sites.
Due to the radiopaque marker bands located throughout the treatment zone dec aimed at improving imaging, the treatment zones range from 20 cm to 50 cm. The working status, alarms, and treatment times can be easily read remotely at a glance.
ViperⓇUltrasonic Pharmacomechanical Thrombolysis Catheter is a minimally invasive system for dissolving thrombus that is designed for controlled ultrasonic infusion therapy of tPA along with US waves. It increases the effects of tPA by thinning the fibrin and increasing porosity. tPA can be pushed deeper inside the thrombus, increasing the effectiveness of the drug.
Targets the Thrombus Safely
- Lowers the risk of bleeding and other complications.
- Dissolves clots without damaging vessels, valves, or walls.
IT IS A 15-MINUTE PROCEDURE.THE PROCEDURE USES INTRAVASCULAR ULTRASOUND-ASSISTED THROMBOLYSIS WITH A TISSUE PLASMINOGEN ACTIVATOR (TPA)
Thanks to the piezo core line located in the center of the catheter, it emits ultrasonic waves and simultaneously delivers thrombolytic drugs.
| Order Number | Catheter Diameter | Working Length | Treatment Zone |
| CR1026 | 5.0 Fr | 100 cm | 6 cm |
| CR1027 | 5.0 Fr | 100 cm | 12 cm |
| CR1028 | 5.0 Fr | 100 cm | 18 cm |
| CR1029 | 5.0 Fr | 100 cm | 24 cm |
| CR1030 | 5.0 Fr | 100 cm | 30 cm |
| CR1031 | 5.0 Fr | 100 cm | 40 cm |
| CR1032 | 5.0 Fr | 100 cm | 50 cm |
| CR1033 | 5.0 Fr | 135 cm | 12 cm |
| CR1034 | 5.0 Fr | 135 cm | 30 cm |
| CR1035 | 5.0 Fr | 135 cm | 40 cm |
| CR1036 | 5.0 Fr | 135 cm | 50 cm |
| CR1037 | 5.0 Fr | 150 cm | 12 cm |
| CR1038 | 5.0 Fr | 150 cm | 30 cm |
| CR1039 | 5.0 Fr | 150 cm | 40 cm |
| CR1040 | 5.0 Fr | 150 cm | 50 cm |
